TRILOGIQ (ALTRI.PA) Fundamental Analysis & Valuation

EPA:ALTRI • FR0010397901

4.84 EUR
-0.04 (-0.82%)
Last: Mar 9, 2026, 07:00 PM

This ALTRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, ALTRI scores 5 out of 10 in our fundamental rating. ALTRI was compared to 109 industry peers in the Machinery industry. ALTRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALTRI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. ALTRI.PA Profitability Analysis

1.1 Basic Checks

  • ALTRI had positive earnings in the past year.
  • ALTRI had a positive operating cash flow in the past year.
  • In multiple years ALTRI reported negative net income over the last 5 years.
  • ALTRI had a positive operating cash flow in 4 of the past 5 years.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

  • ALTRI has a Return On Assets (2.53%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 2.80%, ALTRI is doing worse than 66.06% of the companies in the same industry.
  • ALTRI has a Return On Invested Capital of 0.57%. This is in the lower half of the industry: ALTRI underperforms 77.98% of its industry peers.
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROIC 0.57%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

  • ALTRI has a Profit Margin of 4.57%. This is in the better half of the industry: ALTRI outperforms 60.55% of its industry peers.
  • In the last couple of years the Profit Margin of ALTRI has grown nicely.
  • ALTRI has a Operating Margin of 1.16%. This is in the lower half of the industry: ALTRI underperforms 78.90% of its industry peers.
  • In the last couple of years the Operating Margin of ALTRI has grown nicely.
  • Looking at the Gross Margin, with a value of 63.63%, ALTRI belongs to the top of the industry, outperforming 88.07% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALTRI has grown nicely.
Industry RankSector Rank
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20 -20 40 60

9

2. ALTRI.PA Health Analysis

2.1 Basic Checks

  • ALTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ALTRI has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALTRI remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for ALTRI has been reduced compared to a year ago.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2022 2023 2024 2025 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • ALTRI has an Altman-Z score of 5.31. This indicates that ALTRI is financially healthy and has little risk of bankruptcy at the moment.
  • ALTRI's Altman-Z score of 5.31 is amongst the best of the industry. ALTRI outperforms 92.66% of its industry peers.
  • ALTRI has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.01, ALTRI belongs to the top of the industry, outperforming 99.08% of the companies in the same industry.
  • ALTRI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALTRI (0.00) is better than 97.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.31
ROIC/WACC0.07
WACC8.17%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • ALTRI has a Current Ratio of 9.71. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
  • ALTRI's Current ratio of 9.71 is amongst the best of the industry. ALTRI outperforms 100.00% of its industry peers.
  • A Quick Ratio of 8.58 indicates that ALTRI has no problem at all paying its short term obligations.
  • ALTRI has a better Quick ratio (8.58) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 9.71
Quick Ratio 8.58
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2022 2023 2024 2025 10M 20M 30M 40M

1

3. ALTRI.PA Growth Analysis

3.1 Past

  • The earnings per share for ALTRI have decreased strongly by -32.65% in the last year.
  • The Earnings Per Share has been growing by 29.14% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -3.60% in the past year.
  • ALTRI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.29% yearly.
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

4

4. ALTRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.69, the valuation of ALTRI can be described as correct.
  • Based on the Price/Earnings ratio, ALTRI is valued a bit cheaper than the industry average as 75.23% of the companies are valued more expensively.
  • ALTRI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
  • The Price/Forward Earnings ratio is 13.43, which indicates a correct valuation of ALTRI.
  • 66.06% of the companies in the same industry are more expensive than ALTRI, based on the Price/Forward Earnings ratio.
  • ALTRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.69
Fwd PE 13.43
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ALTRI is valued cheaply inside the industry as 81.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.22
EV/EBITDA -24.87
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ALTRI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALTRI!.
Industry RankSector Rank
Dividend Yield 0%

ALTRI.PA Fundamentals: All Metrics, Ratios and Statistics

TRILOGIQ

EPA:ALTRI (3/9/2026, 7:00:00 PM)

4.84

-0.04 (-0.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-24
Earnings (Next)N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap18.10M
Revenue(TTM)23.20M
Net Income(TTM)1.06M
Analysts86.67
Price Target6.12 (26.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.69
Fwd PE 13.43
P/S 0.78
P/FCF 8.22
P/OCF 7.5
P/B 0.48
P/tB 0.48
EV/EBITDA -24.87
EPS(TTM)0.29
EY5.99%
EPS(NY)0.36
Fwd EY7.45%
FCF(TTM)0.59
FCFY12.17%
OCF(TTM)0.65
OCFY13.34%
SpS6.2
BVpS10.14
TBVpS10.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.13
Profitability
Industry RankSector Rank
ROA 2.53%
ROE 2.8%
ROCE 0.7%
ROIC 0.57%
ROICexc 1.67%
ROICexgc 1.67%
OM 1.16%
PM (TTM) 4.57%
GM 63.63%
FCFM 9.49%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.02
Cap/Depr 24.77%
Cap/Sales 0.91%
Interest Coverage 250
Cash Conversion 214.48%
Profit Quality 207.83%
Current Ratio 9.71
Quick Ratio 8.58
Altman-Z 5.31
F-Score6
WACC8.17%
ROIC/WACC0.07
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.11%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.85%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-14.72%
OCF growth 3YN/A
OCF growth 5Y-3.83%

TRILOGIQ / ALTRI.PA FAQ

What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALTRI.PA.


What is the valuation status for ALTRI stock?

ChartMill assigns a valuation rating of 4 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Fairly Valued.


How profitable is TRILOGIQ (ALTRI.PA) stock?

TRILOGIQ (ALTRI.PA) has a profitability rating of 4 / 10.


What is the financial health of TRILOGIQ (ALTRI.PA) stock?

The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.


What is the expected EPS growth for TRILOGIQ (ALTRI.PA) stock?

The Earnings per Share (EPS) of TRILOGIQ (ALTRI.PA) is expected to decline by -2.78% in the next year.